Dr. Sonia Ramamoorthy, MD

Dr. Ramamoorthy practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Ramamoorthy's NPI, 1801812656, was assigned on July 14, 2006. Dr. Ramamoorthy graduated from Boston University School Of Medicine in 1996. Dr. Ramamoorthy holds California license A65709.

Dr. Ramamoorthy's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Ramamoorthy's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Ramamoorthy is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramamoorthy practices. Vendor and product names are available with a free account.

Surgery is Dr. Ramamoorthy's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Ramamoorthy is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dr. Ramamoorthy is licensed in California.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Ramamoorthy treats.

CMS data shows 167 Medicare services from Dr. Ramamoorthy across 5 procedure codes in 2024, for 127 Medicare patients. Medicare paid $16,682 for them. Every service was in an office.

CMS counts 127 Medicare patients who saw Dr. Ramamoorthy in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high cholesterol, and 61% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramamoorthy's median patient age at 52, with 55% women.

In 2024, Dr. Ramamoorthy wrote 52 Medicare Part D claims for 30 patients. 88% of them were for generic drugs. CMS names the drug for 47 of them, across 1 drug with 11 or more claims each, at $8,069 in total drug cost. In 2019, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Ramamoorthy for performance year 2024, reported as part of a group. Dr. Ramamoorthy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ramamoorthy as offering telehealth. CMS counts 22 procedures of colonoscopy by Dr. Ramamoorthy, more than 49% of the clinicians it reports for that procedure.

Dmand AI links 121 papers to Dr. Ramamoorthy, published from 2002 to 2024. 2019 was the busiest year, with 10. The most frequent topics are Postoperative Complications, Colectomy and Rectal Neoplasms. Dr. Ramamoorthy has published most often in Surg Endosc. Dr. Ramamoorthy's most frequent co-authors are Samuel G. Eisenstein, MD, Santiago Horgan and Lisa A. Parry, MD.

Dmand AI links Dr. Ramamoorthy to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Ileus, Rectal Diseases and Colorectal Neoplasms.

CMS Open Payments shows 256 general payments to Dr. Ramamoorthy from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Medical Device Business Services, Inc. paid the most, $64,073.

Dmand AI lists 7 awards for Dr. Ramamoorthy, most recently America's Top Doctors in 2023.

Dr. Ramamoorthy graduated from Boston University School Of Medicine in 1996. Dr. Ramamoorthy is a member of ACS.

Dr. Ramamoorthy is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.